.svg){kind=logo}
.svg){kind=logo}
.svg){kind=logo}
International Research
Overview
TheroGenX operates at the intersection of biologic science, extracellular matrix technologies, and emerging cellular research, supporting a global network of research institutions, biotechnology companies, and distribution partners.
Through a vertically integrated platform, TherogenX provides high-quality biologic materials for research, laboratory, and investigational use, while maintaining alignment with U.S. FDA regulatory frameworks and international compliance standards.
As global demand continues to grow across regenerative medicine and biologic sciences, TherogenX is positioned to deliver consistent, scalable, and scientifically grounded solutions to partners worldwide.
Global Scientific Foundation
These global research initiatives—ranging from early-stage laboratory studies to advanced translational programs—continue to expand the understanding of how biologic materials interact within complex cellular environments.
The study of biologic systems—including cellular signaling, tissue structure, and regenerative pathways—has evolved over more than a century of scientific advancement. Early research in cell biology and tissue behavior has progressed into modern investigations focused on:
- Extracellular matrix (ECM) structure and function
- Cellular communication and signaling pathways
- Extracellular vesicles, including exosomes
- Tissue microenvironment and structural interaction models
Today, leading institutions across North America, Europe, Asia, and the Middle East are actively conducting research in areas such as:
- Immune system signaling and regulatory pathways
- Investigational models involving autoimmune and inflammatory conditions
- Neurological and musculoskeletal research
- Soft tissue and structural interface studies
- Extracellular vesicle (exosome) communication and signaling
TheroGenX Research & Biologic Platform
TheroGenX supports a wide range of scientific and product development initiatives through biologic materials centered around:
Extracellular Matrix (ECM) Systems
Structurally derived biologic matrices designed for the study of tissue interfaces, physical support environments, and biologic architecture.
Biologic Signaling Components
Materials utilized in research exploring cellular communication, structural signaling, and biologic coordination.
Extracellular Vesicle & Exosome Research
An emerging and rapidly expanding area of global research focused on nanoscale vesicles involved in intercellular signaling and communication pathways.
Our platform enables partners to conduct laboratory research, preclinical evaluation, and product innovation using materials produced with an emphasis on consistency, structure, and reproducibility.
Global Partnerships & Distribution
TheroGenX collaborates with:
- International research institutions and academic centers
- Biotechnology and pharmaceutical organizations
- Translational research groups
- Regional and global distribution partners
Our infrastructure is designed to support reliable, repeatable, and scalable supply chains, ensuring consistent access to biologic materials across multiple global markets.
We provide partners with:
- Standardized material specifications
- Scalable production capabilities
- Batch consistency and repeatability
- Logistics and distribution support for international delivery
Quality, Compliance & Manufacturing Standards
TheroGenX is committed to maintaining the highest standards of quality, safety, and process control across all biologic materials.
Regulatory Alignment (U.S. & International)
TheroGenX operates in alignment with:
- U.S. Food and Drug Administration (FDA) regulations
- 21 CFR Part 1271 for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
- Current Good Tissue Practices (cGTP)
- International regulatory expectations for biologic materials
Our systems are structured to support compliance with both U.S. regulatory frameworks and international market requirements.
Quality Management System (QMS)
Our operations are guided by a comprehensive Quality Management System designed to ensure:
- Product consistency and reproducibility
- Full lifecycle traceability
- Continuous quality improvement
Our QMS incorporates principles aligned with:
- ISO 13485 (medical-related quality systems)
- ISO 9001 (quality management and process control)
Good Manufacturing & Tissue Practices
TheroGenX follows industry-recognized standards for biologic processing:
- cGTP-compliant processes under FDA guidelines
- GMP-aligned environments for controlled biologic handling
- Aseptic processing techniques
- Controlled and monitored production conditions
- Validated workflows across sourcing, processing, and packaging
These systems ensure product integrity, safety, and consistency across all batches.
Donor Screening & Tissue Qualification
All biologic materials are managed through strict qualification protocols:
- Comprehensive donor screening and medical review
- Infectious disease testing in accordance with regulatory standards
- Full traceability from donor to final product
- Controlled chain-of-custody procedures
Quality Control & Product Testing
Multi-level quality control systems ensure materials meet defined specifications:
- Structural and visual evaluation
- Lot-to-lot consistency verification
- Environmental monitoring
- Sterility and bioburden testing (as applicable)
- Stability and storage validation
Traceability & Documentation
TheroGenX maintains a fully integrated tracking system providing:
- End-to-end traceability
- Lot identification and batch tracking
- Audit-ready documentation
- Regulatory transparency for partners
Storage, Handling & Distribution
All materials are managed under validated conditions:
- Controlled temperature storage environments
- Temperature-monitored logistics
- Protective packaging systems
- Chain-of-custody tracking across global distribution
Commitment to Scientific Advancement
TheroGenX remains actively engaged in supporting the advancement of biologic science through:
- Ongoing collaboration with research institutions
- Monitoring emerging fields such as exosome and cell-based research
- Supporting innovation in biologic materials and structural systems
Our platform is designed to evolve alongside the global scientific community, enabling continued exploration and development in next-generation biologic technologies.
Regulatory & Use Statement
All products supplied by TherogenX are intended for research, laboratory, and investigational use only and are not intended for clinical application in regions where regulatory approvals have not been established.
International partners are responsible for ensuring compliance with all applicable regulatory requirements within their respective jurisdictions.
Global Partnership Opportunities
TheroGenX welcomes collaboration with qualified organizations seeking:
- High-quality biologic materials
- Scalable and consistent supply
- A scientifically grounded and regulatory-aligned platform
- Long-term global distribution and development partnerships
